20 patients (41.7%) needed dose reduction and reasons of dose interruptions were fatigue (40%), AST/ALT increase (26.7%), renal dysfunction (20%), NH3 increase (6.7%), nausea (6.7%), decreased appetite (6.7%), infection (6.7%), respectively. This evidence concerns the gene GPT and Abnormal renal physiology.